RadNet (RDNT) Competitors $49.25 -0.46 (-0.93%) Closing price 03/21/2025 04:00 PM EasternExtended Trading$49.50 +0.25 (+0.51%) As of 03/21/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock RDNT vs. FMS, HIMS, OPCH, GH, SHC, SGRY, BTSG, PRVA, CON, and LFSTShould you be buying RadNet stock or one of its competitors? The main competitors of RadNet include Fresenius Medical Care (FMS), Hims & Hers Health (HIMS), Option Care Health (OPCH), Guardant Health (GH), Sotera Health (SHC), Surgery Partners (SGRY), BrightSpring Health Services (BTSG), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), and LifeStance Health Group (LFST). These companies are all part of the "healthcare" industry. RadNet vs. Fresenius Medical Care Hims & Hers Health Option Care Health Guardant Health Sotera Health Surgery Partners BrightSpring Health Services Privia Health Group Concentra Group Holdings Parent LifeStance Health Group Fresenius Medical Care (NYSE:FMS) and RadNet (NASDAQ:RDNT) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, profitability, valuation, community ranking, analyst recommendations, dividends, earnings, media sentiment and risk. Does the MarketBeat Community believe in FMS or RDNT? Fresenius Medical Care received 69 more outperform votes than RadNet when rated by MarketBeat users. However, 66.17% of users gave RadNet an outperform vote while only 54.72% of users gave Fresenius Medical Care an outperform vote. CompanyUnderperformOutperformFresenius Medical CareOutperform Votes42354.72% Underperform Votes35045.28% RadNetOutperform Votes35466.17% Underperform Votes18133.83% Do analysts rate FMS or RDNT? Fresenius Medical Care presently has a consensus price target of $25.30, indicating a potential upside of 4.18%. RadNet has a consensus price target of $76.75, indicating a potential upside of 55.84%. Given RadNet's stronger consensus rating and higher possible upside, analysts plainly believe RadNet is more favorable than Fresenius Medical Care.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fresenius Medical Care 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33RadNet 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 2 Strong Buy rating(s) 3.40 Which has higher valuation and earnings, FMS or RDNT? Fresenius Medical Care has higher revenue and earnings than RadNet. Fresenius Medical Care is trading at a lower price-to-earnings ratio than RadNet, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFresenius Medical Care$19.34B0.74$540.07M$0.9924.53RadNet$1.83B1.99$3.04M$0.031,641.67 Does the media refer more to FMS or RDNT? In the previous week, RadNet had 6 more articles in the media than Fresenius Medical Care. MarketBeat recorded 13 mentions for RadNet and 7 mentions for Fresenius Medical Care. Fresenius Medical Care's average media sentiment score of 1.04 beat RadNet's score of 1.02 indicating that Fresenius Medical Care is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fresenius Medical Care 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive RadNet 8 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, FMS or RDNT? Fresenius Medical Care has a beta of 0.99, indicating that its share price is 1% less volatile than the S&P 500. Comparatively, RadNet has a beta of 1.85, indicating that its share price is 85% more volatile than the S&P 500. Do insiders and institutionals have more ownership in FMS or RDNT? 8.4% of Fresenius Medical Care shares are owned by institutional investors. Comparatively, 77.9% of RadNet shares are owned by institutional investors. 5.1% of RadNet shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Is FMS or RDNT more profitable? Fresenius Medical Care has a net margin of 3.43% compared to RadNet's net margin of -0.25%. Fresenius Medical Care's return on equity of 6.04% beat RadNet's return on equity.Company Net Margins Return on Equity Return on Assets Fresenius Medical Care3.43% 6.04% 2.69% RadNet -0.25%4.29%1.45% SummaryRadNet beats Fresenius Medical Care on 10 of the 19 factors compared between the two stocks. Remove Ads Get RadNet News Delivered to You Automatically Sign up to receive the latest news and ratings for RDNT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RDNT vs. The Competition Export to ExcelMetricRadNetMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.65B$2.91B$5.73B$8.13BDividend YieldN/A21.62%4.39%4.04%P/E Ratio-703.4713.4524.7419.07Price / Sales1.99209.60398.9891.58Price / Cash18.8157.5638.1634.64Price / Book4.184.697.104.43Net Income$3.04M-$22.21M$3.20B$247.36M7 Day Performance5.82%3.98%1.98%1.98%1 Month Performance-17.19%-9.02%3.59%-6.10%1 Year Performance2.52%3.61%14.49%3.48% RadNet Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RDNTRadNet4.2411 of 5 stars$49.25-0.9%$76.75+55.8%+2.5%$3.65B$1.83B-703.478,970Analyst UpgradeInsider TradeNews CoveragePositive NewsHigh Trading VolumeFMSFresenius Medical Care3.4906 of 5 stars$24.18+0.6%$25.30+4.6%+29.6%$14.20B$19.34B19.991,358Positive NewsGap DownHIMSHims & Hers Health2.176 of 5 stars$34.68+4.6%$37.23+7.4%+112.9%$7.74B$1.48B79.141,046Analyst ForecastInsider TradeOPCHOption Care Health4.137 of 5 stars$33.88+3.7%$33.00-2.6%+5.8%$5.59B$5.00B28.445,600Positive NewsGHGuardant Health3.6618 of 5 stars$42.94+0.1%$48.40+12.7%+167.2%$5.34B$739.02M-12.161,790SHCSotera Health2.7718 of 5 stars$11.93+3.0%$15.92+33.4%+5.3%$3.39B$1.10B47.833,000Positive NewsSGRYSurgery Partners2.6867 of 5 stars$24.41+3.4%$36.63+50.1%-12.9%$3.12B$3.11B-50.9113,500BTSGBrightSpring Health Services2.3577 of 5 stars$17.43+0.1%$21.67+24.3%+87.8%$3.05B$11.27B-67.0335,000PRVAPrivia Health Group3.7134 of 5 stars$23.22-2.2%$26.67+14.9%+19.0%$2.79B$1.74B231.231,102Analyst ForecastPositive NewsCONConcentra Group Holdings ParentN/A$21.04+1.2%$28.38+34.8%N/A$2.69B$1.90B13.9811,000Ex-DividendAnalyst ForecastNews CoveragePositive NewsLFSTLifeStance Health Group2.3626 of 5 stars$6.89-0.5%$8.63+25.3%+15.5%$2.66B$1.25B-26.569,325Insider TradePositive News Remove Ads Related Companies and Tools Related Companies Fresenius Medical Care Alternatives Hims & Hers Health Alternatives Option Care Health Alternatives Guardant Health Alternatives Sotera Health Alternatives Surgery Partners Alternatives BrightSpring Health Services Alternatives Privia Health Group Alternatives Concentra Group Holdings Parent Alternatives LifeStance Health Group Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RDNT) was last updated on 3/24/2025 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RadNet, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RadNet With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.